CardioGenomics
overview researchers projects data publications events links
What's New
Candidate Genes
How to Cite Us
FAQ's
Other PGA's
Contact Us
Sign In
View other projects: 1  2   3   4   5  

Overview of Project 3:

Familial hypertrophic cardiomyopathy (HCM) is inherited as an autosomal dominant disease that is caused by dominant-negative-acting sarcomere protein gene mutations. Mutations in beta-cardiac myosin heavy chain, cardiac actin, cardiac troponin T, alpha-tropomyosin, cardiac troponin I, cardiac myosin-binding protein C, and the myosin light chains have all been shown to cause HCM. We hypothesize that the number of sarcomere protein gene mutations that can cause HCM is finite, and we propose to identify the complete complement of such mutations. Knowledge of this complete set of mutations will provide insights into the mechanisms by which these mutations cause cardiac disease as well as provide useful tools for the genetic diagnoses of these conditions. In order to define the complete set of disease-causing sarcomere protein gene mutations, we are screening the eight genes encoding sarcomere protein genes in HCM patients. This complete set of HCM-causing mutations will also allow more rapid and less expensive diagnostic tests for HCM.

A second goal of these studies is to provide a database that allows correlation of HCM severity and mutation. Many HCM-causing mutations are found in patients with several affected family members. These affected family members can provide useful clinical information regarding the severity of a particular mutation. During the first three years of this study limited family information has been provided. However, we have developed procedures which should allow the more rapid collection of additional family information over the next several years.

Methodology

View our methods and protocols for clinical evaluations, PCR and sequencing reactions, data analysis, and mutation confirmation.

Top of Page

Mutation Database

In keeping with our policy of making our research tools available to the community at large, we have compiled a database of published information about known sarcomere mutations, as well as exon, PCR primer, and amplimer data for each of the genes we are examining.

Individuals interested in participating in a research study may contact Barbara McDonough, R.N., for more information.

Top of Page

. ;

Top of Page


Participants

Position

Jonathan G. Seidman Principal Investigator
Christine Seidman Co- Principal Investigator
Daniel Levy Co-Investigator
Emelia J. Benjamin Co-Investigator
Christopher O'Donnell Co-Investigator
Ramachandran S. Vasan Co-Investigator
Barbara McDonough RN Clinical Coordinator
Steven DePalma Research Specialist
Hiroyuki Morita Research Associate
Meredith Moore Research Associate
Josh Gorham Research Technician
Kevin Merk Research Technician
Scott Barr Research Technician

Project Publications

Cardiovascular Genetics Center

An abnormal Ca(2+) response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy
Comparison of two murine models of familial hypertrophic cardiomyopathy
Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations
Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice
Familial hypertrophic cardiomyopathy and atrial fibrillation caused by Arg663His beta-cardiac myosin heavy chain mutation
Homozygous mutation in cardiac troponin T: Implications for hypertrophic cardiomyopathy
Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy
The genetic basis for cardiomyopathy: From mutation identification to mechanistic paradigms (Review)
The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model
Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy
Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly
Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban
Molecular epidemiology of hypertrophic cardiomyopathy
Consequences of pressure overload on sarcomere protein mutation-induced hypertrophic cardiomyopathy


Affiliated Institutions  | Sponsored by the National Heart, Lung, and Blood Institute
Copyright 2001-2003, CardioGenomics   | Designed by Digizyme